Compare PETS & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PETS | RDZN |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Blank Checks |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.7M | 75.2M |
| IPO Year | N/A | N/A |
| Metric | PETS | RDZN |
|---|---|---|
| Price | $3.42 | $2.15 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.20 | N/A |
| AVG Volume (30 Days) | ★ 7.7M | 174.7K |
| Earning Date | 02-09-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $198,265,000.00 | $48,035,296.00 |
| Revenue This Year | N/A | $40.39 |
| Revenue Next Year | $2.98 | $64.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.42 |
| 52 Week Low | $1.57 | $0.68 |
| 52 Week High | $5.58 | $2.99 |
| Indicator | PETS | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 66.75 | 77.41 |
| Support Level | $1.69 | $1.62 |
| Resistance Level | $3.89 | $1.71 |
| Average True Range (ATR) | 0.39 | 0.11 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 72.73 | 92.65 |
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.